S. Lale Tokgözoğlu

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk

Michelle L. O’Donoghue, Sergio Fazio, Robert P. Giugliano et al. · Circulation · 2019 · 895 citations · Full text

An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial

Brian A. Bergmark, Michelle L. O’Donoghue, Sabina A. Murphy et al. · JAMA Cardiology · 2020 · 124 citations · Full text

Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin

Robert P. Giugliano, Anthony Keech, Sabina A. Murphy et al. · JAMA Cardiology · 2017 · 103 citations · Full text

Methylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate

S. Lale Tokgözoğlu, Mehmet Alikaşifoğlu, İbrahim Ünsal et al. · Heart · 1999 · 78 citations · Full text

Plasma myeloperoxidase is related to the severity of coronary artery disease

Bünyamin Yavuz, Ali Deniz, S. Lale Tokgözoğlu et al. · Acta Cardiologica · 2008 · 53 citations